http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013034174-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d23a396143a99462eb1dac5f22fda128
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d1d8020d3c8130d41f330cf01b41752b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ea7c64dd9e45bf0ac361d8f2fc92df57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6ee3ae2f4646ea043da86b4bc7e8077a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_165ce119cfe23566dc52d00440e463f1
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-64
filingDate 2011-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88b6d61b104157d153fd112dbc754806
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_604cb46e75dc9ac5aa5289da23191e0a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_418052e1d139b89f9f3df15298ecc2e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_faeccff794422c6f6cb45d89a44e1299
publicationDate 2013-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2013034174-A1
titleOfInvention Solid preparations of pioglitazone and glimepiride
abstract The present invention relates to solid preparations and combinations of pioglitazone and glimepiride, and a method for their preparation. The method comprises granulating pioglitazone and glimepiride with other excipients individually, and blending the both granulates to obtain solid oral dosage forms with improved stability and dissolution profile.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104523712-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104288161-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023165971-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104523712-B
priorityDate 2011-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2228066-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005041962-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004147564-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004266830-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009120844-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1174135-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007072992-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60560
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406307
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21896633
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3476
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18432401
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID29010894
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229007527
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406305
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411035
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406306
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396175
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411036

Total number of triples: 53.